Cargando…
The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines
Breast cancer affects roughly one in eight women over their lifetime and is a leading cause of cancer-related death in women. While outcomes have improved in recent years, prognosis remains poor for patients who present with either disseminated disease or aggressive molecular subtypes. Cancer immuno...
Autores principales: | Gordon, Benjamin, Gadi, Vijayakrishna K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565925/ https://www.ncbi.nlm.nih.gov/pubmed/32937885 http://dx.doi.org/10.3390/vaccines8030529 |
Ejemplares similares
-
Current progress in the development of prophylactic and therapeutic vaccines
por: Li, Tingting, et al.
Publicado: (2022) -
Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines
por: Borovjagin, Anton V., et al.
Publicado: (2014) -
Prophylactic and therapeutic vaccines for obesity
por: Na, Ha-Na, et al.
Publicado: (2014) -
Case-Control Study of Fetal Microchimerism and Breast Cancer
por: Gadi, Vijayakrishna K., et al.
Publicado: (2008) -
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
por: Phua, Kyle K. L., et al.
Publicado: (2014)